Literature DB >> 17918739

Region-specific differentiation of embryonic stem cell-derived neural progenitor transplants into the adult mouse hippocampus following seizures.

Joseph E Carpentino1, Nathaniel W Hartman, Laura B Grabel, Janice R Naegele.   

Abstract

Embryonic stem (ES) cells can generate neural progenitors and neurons in vitro and incorporate into the adult central nervous system (CNS) following transplantation, suggesting their therapeutic potential for treating neurological disorders. However, our understanding of the conditions that direct ES-derived neural progenitor (ESNP) migration and differentiation within different regions of the adult CNS is incomplete. Rodents treated with the chemoconvulsant kainic acid (KA) experience seizures and display hippocampal sclerosis, as well as enhanced hippocampal neurogenesis, similar to pathological findings in patients with temporal lobe epilepsy (TLE). To examine the potential for ESNPs to incorporate into the adult hippocampus and differentiate into hippocampal neurons or glia following seizure-induced damage, we compared the fates of ESNPs after they were transplanted into the CA3 region or fimbria 1 week following KA-induced seizures. After 4-8 weeks, ESNPs grafted into the CA3 region had migrated to the dentate gyrus (DG), where a small subset adopted neural stem cell fates and continued to proliferate, based on bromodeoxyuridine uptake. Others differentiated into neuroblasts or dentate granule neurons. In contrast, most ESNPs transplanted into the fimbria migrated extensively along existing fiber tracts and differentiated into oligodendrocytes or astrocytes. Hippocampal grafts in mice not subjected to seizures displayed a marked tendency to form tumors, and this effect was more pronounced in the DG than in the fimbria. Taken together, these data suggest that seizures induce molecular changes in the CA3 region and DG that promote region-specific neural differentiation and suppress tumor formation. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17918739     DOI: 10.1002/jnr.21514

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Stem cells as a potential therapy for epilepsy.

Authors:  Steven N Roper; Dennis A Steindler
Journal:  Exp Neurol       Date:  2012-01-13       Impact factor: 5.330

2.  Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy.

Authors:  Ben Waldau; Bharathi Hattiangady; Ramkumar Kuruba; Ashok K Shetty
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

3.  A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity.

Authors:  Joseph Yanai; Yael Brick-Turin; Sharon Dotan; Rachel Langford; Adi Pinkas; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2009-02-13       Impact factor: 3.763

4.  Interneuron Origins in the Embryonic Porcine Medial Ganglionic Eminence.

Authors:  Mariana L Casalia; Tina Li; Harrison Ramsay; Pablo J Ross; Mercedes F Paredes; Scott C Baraban
Journal:  J Neurosci       Date:  2021-02-26       Impact factor: 6.167

Review 5.  Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.

Authors:  Janice R Naegele; Xu Maisano; Jia Yang; Sara Royston; Efrain Ribeiro
Journal:  Neuropharmacology       Date:  2010-02-08       Impact factor: 5.250

6.  Subventricular zone-derived neural stem cell grafts protect against hippocampal degeneration and restore cognitive function in the mouse following intrahippocampal kainic acid administration.

Authors:  Panagiota Miltiadous; Georgia Kouroupi; Antonios Stamatakis; Paraskevi N Koutsoudaki; Rebecca Matsas; Fotini Stylianopoulou
Journal:  Stem Cells Transl Med       Date:  2013-02-15       Impact factor: 6.940

7.  Long-term seizure suppression and optogenetic analyses of synaptic connectivity in epileptic mice with hippocampal grafts of GABAergic interneurons.

Authors:  Katharine W Henderson; Jyoti Gupta; Stephanie Tagliatela; Elizabeth Litvina; XiaoTing Zheng; Meghan A Van Zandt; Nicholas Woods; Ethan Grund; Diana Lin; Sara Royston; Yuchio Yanagawa; Gloster B Aaron; Janice R Naegele
Journal:  J Neurosci       Date:  2014-10-01       Impact factor: 6.167

8.  Medial Ganglionic Eminence Cells Freshly Obtained or Expanded as Neurospheres Show Distinct Cellular and Molecular Properties in Reducing Epileptic Seizures.

Authors:  Simone A A Romariz; Daisyléa S Paiva; Layla T Galindo; Gabriela F Barnabé; Vivian A Guedes; Cesario V Borlongan; Beatriz M Longo
Journal:  CNS Neurosci Ther       Date:  2016-10-21       Impact factor: 5.243

Review 9.  Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.

Authors:  Steven C Schachter; John Guttag; Steven J Schiff; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2009-09       Impact factor: 2.937

10.  Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.

Authors:  Scott C Baraban; Derek G Southwell; Rosanne C Estrada; Daniel L Jones; Joy Y Sebe; Clara Alfaro-Cervello; Jose M García-Verdugo; John L R Rubenstein; Arturo Alvarez-Buylla
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.